Therapeutic cell compositions and methods of manufacturing and use thereof
US12252545B2 · kind B2 · utility
0Cited by
68References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2021 |
| Grant date | Mar 18, 2025 |
| Priority date | — |
| Expiry date | Oct 25, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions and methods for making and using engineered killer phagocytic cells for immunotherapy in cancer or infection by expressing a chimeric antigen receptor having an enhanced phagocytic activity, the chimeric receptor is encoded by a recombinant nucleic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.